{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:11:18Z","timestamp":1767143478939,"version":"build-2238731810"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,3]],"date-time":"2013-02-03T00:00:00Z","timestamp":1359849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s13277-013-0657-7","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T21:10:03Z","timestamp":1359753003000},"page":"1155-1160","source":"Crossref","is-referenced-by-count":5,"title":["Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Yuhao","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,3]]},"reference":[{"key":"657_CR1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(09)61397-0","volume":"374","author":"JF Thompson","year":"2009","unstructured":"Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma in the era of molecular profiling. Lancet. 2009;374:362\u20135.","journal-title":"Lancet"},{"key":"657_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3322\/caac.20074","volume":"60","author":"DS Rigel","year":"2010","unstructured":"Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25\u00a0years beyond the abcds. CA Cancer J Clin. 2010;60:301\u201316.","journal-title":"CA Cancer J Clin"},{"key":"657_CR3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445:851\u20137.","journal-title":"Nature"},{"key":"657_CR4","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1200\/JCO.2007.14.6423","volume":"26","author":"JM Kirkwood","year":"2008","unstructured":"Kirkwood JM, Tarhini AA, Panelli MC, Moschos SJ, Zarour HM, Butterfield LH, et al. Next generation of immunotherapy for melanoma. J Clin Oncol. 2008;26:3445\u201355.","journal-title":"J Clin Oncol"},{"key":"657_CR5","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1101\/gad.1437206","volume":"20","author":"L Chin","year":"2006","unstructured":"Chin L, Garraway LA, Fisher DE. Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev. 2006;20:2149\u201382.","journal-title":"Genes Dev"},{"key":"657_CR6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nature11624","volume":"491","author":"D Mitra","year":"2012","unstructured":"Mitra D, Luo X, Morgan A, Wang J, Hoang MP, Lo J, et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background. Nature. 2012;491:449\u201353.","journal-title":"Nature"},{"key":"657_CR7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s13277-011-0218-x","volume":"32","author":"A Diaz-Lagares","year":"2011","unstructured":"Diaz-Lagares A, Alegre E, Arroyo A, Gonzalez-Cao M, Zudaire ME, Viteri S, et al. Evaluation of multiple serum markers in advanced melanoma. Tumour Biol. 2011;32:1155\u201361.","journal-title":"Tumour Biol"},{"key":"657_CR8","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s13277-012-0480-6","volume":"33","author":"L Vizkeleti","year":"2012","unstructured":"Vizkeleti L, Ecsedi S, Rakosy Z, Orosz A, Lazar V, Emri G, et al. The role of ccnd1 alterations during the progression of cutaneous malignant melanoma. Tumour Biol. 2012;33:2189\u201399.","journal-title":"Tumour Biol"},{"key":"657_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13277-011-0253-7","volume":"33","author":"A Kumar","year":"2012","unstructured":"Kumar A, Pant MC, Singh HS, Khandelwal S. Reduced expression of DNA repair genes (xrcc1, xpd, and ogg1) in squamous cell carcinoma of head and neck in north India. Tumour Biol. 2012;33:111\u20139.","journal-title":"Tumour Biol"},{"key":"657_CR10","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s13277-012-0470-8","volume":"33","author":"R Nar","year":"2012","unstructured":"Nar R, Bedir A, Alacam H, Kilinc V, Avci B, Salis O, et al. The effect of ouabain on mitochondrial DNA damage in hepg2 cell lines. Tumour Biol. 2012;33:2107\u201315.","journal-title":"Tumour Biol"},{"key":"657_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cell.2010.01.004","volume":"140","author":"M Ransom","year":"2010","unstructured":"Ransom M, Dennehey BK, Tyler JK. Chaperoning histones during DNA replication and repair. Cell. 2010;140:183\u201395.","journal-title":"Cell"},{"key":"657_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrc3088","volume":"11","author":"AJ Deans","year":"2011","unstructured":"Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer. 2011;11:467\u201380.","journal-title":"Nat Rev Cancer"},{"key":"657_CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","volume":"79","author":"MR Lieber","year":"2010","unstructured":"Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181\u2013211.","journal-title":"Annu Rev Biochem"},{"key":"657_CR14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/mutage\/17.6.463","volume":"17","author":"S Benhamou","year":"2002","unstructured":"Benhamou S, Sarasin A. Ercc2\/xpd gene polymorphisms and cancer risk. Mutagenesis. 2002;17:463\u20139.","journal-title":"Mutagenesis"},{"key":"657_CR15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-59745-416-2_16","volume":"471","author":"J Jiang","year":"2009","unstructured":"Jiang J, Zhang X, Yang H, Wang W. Polymorphisms of DNA repair genes: Adprt, xrcc1, and xpd and cancer risk in genetic epidemiology. Methods Mol Biol. 2009;471:305\u201333.","journal-title":"Methods Mol Biol"},{"key":"657_CR16","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1158\/1055-9965.EPI-11-0520","volume":"20","author":"S Zhong","year":"2011","unstructured":"Zhong S, Nukui T, Buch S, Diergaarde B, Weissfeld LA, Grandis J, et al. Effects of ercc2 lys751gln (a35931c) and ccnd1 (g870a) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent. Cancer Epidemiol Biomarkers Prev. 2011;20:2429\u201337.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"657_CR17","doi-asserted-by":"crossref","first-page":"e43431","DOI":"10.1371\/journal.pone.0043431","volume":"7","author":"H Xue","year":"2012","unstructured":"Xue H, Lu Y, Lin B, Chen J, Tang F, Huang G. The effect of xpd\/ercc2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. PLoS One. 2012;7:e43431.","journal-title":"PLoS One"},{"key":"657_CR18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11033-011-0710-9","volume":"39","author":"Z Feng","year":"2012","unstructured":"Feng Z, Ni Y, Dong W, Shen H, Du J. Association of ercc2\/xpd polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis. Mol Biol Rep. 2012;39:57\u201369.","journal-title":"Mol Biol Rep"},{"key":"657_CR19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/carcin\/bgl257","volume":"28","author":"JE Povey","year":"2007","unstructured":"Povey JE, Darakhshan F, Robertson K, Bisset Y, Mekky M, Rees J, et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis. 2007;28:1087\u201393.","journal-title":"Carcinogenesis"},{"key":"657_CR20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/carcin\/bgi252","volume":"27","author":"RC Millikan","year":"2006","unstructured":"Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the genes environment and melanoma study. Carcinogenesis. 2006;27:610\u20138.","journal-title":"Carcinogenesis"},{"key":"657_CR21","first-page":"5612","volume":"60","author":"SL Winsey","year":"2000","unstructured":"Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, Harris AL, et al. A variant within the DNA repair gene xrcc3 is associated with the development of melanoma skin cancer. Cancer Res. 2000;60:5612\u20136.","journal-title":"Cancer Res"},{"key":"657_CR22","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1158\/1055-9965.EPI-06-0672","volume":"15","author":"C Li","year":"2006","unstructured":"Li C, Hu Z, Liu Z, Wang LE, Strom SS, Gershenwald JE, et al. Polymorphisms in the DNA repair genes xpc, xpd, and xpg and risk of cutaneous melanoma: a case\u2013control analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:2526\u201332.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"657_CR23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1158\/1055-9965.EPI-04-0846","volume":"14","author":"J Han","year":"2005","unstructured":"Han J, Colditz GA, Liu JS, Hunter DJ. Genetic variation in xpd, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1539\u201344.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"657_CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-005-9151-2","volume":"98","author":"T Debniak","year":"2006","unstructured":"Debniak T, Scott RJ, Huzarski T, Byrski T, Masojc B, van de Wetering T, et al. Xpd common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat. 2006;98:209\u201315.","journal-title":"Breast Cancer Res Treat"},{"key":"657_CR25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.bjc.6601385","volume":"90","author":"A Baccarelli","year":"2004","unstructured":"Baccarelli A, Calista D, Minghetti P, Marinelli B, Albetti B, Tseng T, et al. Xpd gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer. 2004;90:497\u2013502.","journal-title":"Br J Cancer"},{"key":"657_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101\u201329.","journal-title":"Biometrics"},{"key":"657_CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"657_CR28","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719\u201348.","journal-title":"J Natl Cancer Inst"},{"key":"657_CR29","first-page":"179","volume":"20","author":"K Kertat","year":"2008","unstructured":"Kertat K, Rosdahl I, Sun XF, Synnerstad I, Zhang H. The gln\/gln genotype of xpd codon 751 as a genetic marker for melanoma risk and lys\/gln as an important predictor for melanoma progression: A case control study in the Swedish population. Oncol Rep. 2008;20:179\u201383.","journal-title":"Oncol Rep"},{"key":"657_CR30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1470-2045(10)70274-6","volume":"12","author":"E Romano","year":"2011","unstructured":"Romano E, Schwartz GK, Chapman PB, Wolchock JD, Carvajal RD. Treatment implications of the emerging molecular classification system for melanoma. Lancet Oncol. 2011;12:913\u201322.","journal-title":"Lancet Oncol"},{"key":"657_CR31","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2006.06.0442","volume":"25","author":"LA Fecher","year":"2007","unstructured":"Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol. 2007;25:1606\u201320.","journal-title":"J Clin Oncol"},{"key":"657_CR32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.gde.2010.02.001","volume":"20","author":"Y Liu","year":"2010","unstructured":"Liu Y, Shete S, Hosking F, Robertson L, Houlston R, Bondy M. Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev. 2010;20:239\u201344.","journal-title":"Curr Opin Genet Dev"},{"key":"657_CR33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s13277-012-0329-z","volume":"33","author":"T Lindgren","year":"2012","unstructured":"Lindgren T, Stigbrand T, Riklund K, Johansson L, Eriksson D. Gene expression profiling in molt-4 cells during gamma-radiation-induced apoptosis. Tumour Biol. 2012;33:689\u2013700.","journal-title":"Tumour Biol"},{"key":"657_CR34","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/jid.2012.4","volume":"132","author":"L Wheless","year":"2012","unstructured":"Wheless L, Kistner-Griffin E, Jorgensen TJ, Ruczinski I, Berthier-Schaad Y, Kessing B, et al. A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. J Invest Dermatol. 2012;132:1354\u201362.","journal-title":"J Invest Dermatol"},{"key":"657_CR35","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/jid.2012.15","volume":"132","author":"J Cotignola","year":"2012","unstructured":"Cotignola J, Chou JF, Roy P, Mitra N, Busam K, Halpern AC, et al. Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma. J Invest Dermatol. 2012;132:1471\u20138.","journal-title":"J Invest Dermatol"}],"updated-by":[{"DOI":"10.1007\/s13277-017-5487-6","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"record-id":"6678"},{"DOI":"10.1007\/s13277-017-5487-6","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000}}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-0657-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-013-0657-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-0657-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:24:49Z","timestamp":1559474689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-013-0657-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["657"],"URL":"https:\/\/doi.org\/10.1007\/s13277-013-0657-7","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,3]]}}}